The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells
暂无分享,去创建一个
P. Linsley | K. Tung | J. Ledbetter | R. Noelle | S. Agersborg | N. Griggs | Peter S. Linsley | Jeffrey A. Ledbetter | Nathan D. Griggs | Sally S. Agersborg | Randolf J. Noelle | Kenneth S. K. Tung
[1] S. Sugai. [Immunodeficiency with hyper-IgM]. , 2020, Ryoikibetsu shokogun shirizu.
[2] K. Tung,et al. A zona pellucida 3 peptide vaccine induces antibodies and reversible infertility without ovarian pathology. , 1995, Journal of immunology.
[3] R. Karr,et al. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. , 1995, Journal of immunology.
[4] C. Mohan,et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. , 1995, Journal of immunology.
[5] R J Armitage,et al. Humoral immune responses in CD40 ligand-deficient mice , 1994, The Journal of experimental medicine.
[6] A. Aruffo,et al. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. , 1994, The Journal of clinical investigation.
[7] R. Noelle,et al. The role of CD40 in the regulation of humoral and cell-mediated immunity. , 1994, Immunology today.
[8] P. Linsley,et al. Treatment of murine lupus with CTLA4Ig. , 1994, Science.
[9] R. Flavell,et al. Mice deficient for the CD40 ligand. , 1994, Immunity.
[10] P. Linsley,et al. CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.
[11] A. Aruffo,et al. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory , 1994, The Journal of experimental medicine.
[12] P. Linsley,et al. Soluble CTLA-4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model. , 1994, Journal of immunology.
[13] J. Bluestone,et al. The B7 and CD28 receptor families. , 1994, Immunology today.
[14] N. Nabavi,et al. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. , 1994, Immunity.
[15] B. Hausmann,et al. Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo , 1994, The Journal of experimental medicine.
[16] L. Lanier,et al. CD40 preferentially costimulates activation of CD4+ T lymphocytes. , 1994, Journal of immunology.
[17] J. Bluestone,et al. Expression and functional significance of an additional ligand for CTLA-4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Tung,et al. T cell peptide of a self-protein elicits autoantibody to the protein antigen. Implications for specificity and pathogenetic role of antibody in autoimmunity. , 1993, Journal of immunology.
[19] A. Aruffo,et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39 , 1993, The Journal of experimental medicine.
[20] D. Hunt,et al. Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. , 1993, The Journal of clinical investigation.
[21] A. Aruffo,et al. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. , 1993, Science.
[22] P. Linsley,et al. Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes. , 1993, Journal of immunology.
[23] W. Fanslow,et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.
[24] K P Lee,et al. Differential T cell costimulatory requirements in CD28-deficient mice. , 1993, Science.
[25] P. Linsley,et al. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7. , 1993, Cellular immunology.
[26] R. Schwartz. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy , 1992, Cell.
[27] P. Linsley,et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Linsley,et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.
[29] P. Linsley,et al. CTLA-4 is a second receptor for the B cell activation antigen B7 , 1991, The Journal of experimental medicine.
[30] L. Aarden,et al. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. , 1991, The Journal of biological chemistry.
[31] P. Migliorini,et al. Macrophage NO2- production as a sensitive and rapid assay for the quantitation of murine IFN-gamma. , 1991, Journal of immunological methods.
[32] G. Crabtree,et al. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. , 1991, Science.
[33] R. Schwartz,et al. A cell culture model for T lymphocyte clonal anergy. , 1990, Science.
[34] F. Denizot,et al. A new member of the immunoglobulin superfamily—CTLA-4 , 1987, Nature.
[35] R. Schwartz,et al. T‐Cell Unresponsiveness in vivo and in vitro: Fine Specificity of Induction and Molecular Characterization of the Unresponsive State , 1987, Immunological reviews.
[36] Melvin Cohn,et al. A Theory of Self-Nonself Discrimination , 1970, Science.
[37] W. Paul,et al. Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.
[38] K. Tung,et al. Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida. , 1992, The Journal of clinical investigation.
[39] L. Notarangelo,et al. Immunodeficiency with hyper-IgM (HIM). , 1992, Immunodeficiency reviews.
[40] John R. Secor. Ignorance is bliss , 1991 .
[41] E. Unanue,et al. The costimulatory function of antigen-presenting cells. , 1990, Immunology today.
[42] R. Schwartz,et al. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.
[43] K. Lafferty,et al. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. , 1983, Annual review of immunology.